Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2024-01-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding the approval for drug production and registration of a pharmaceutical product. It is a brief update on business development and does not contain financial statements, detailed financial analysis, or regulatory certifications. The document is short (1688 characters) and serves to inform shareholders and investors about a product development milestone. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification. The nature of the announcement is a business update related to product development, which is best classified as a general regulatory announcement or miscellaneous filing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-01-02 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding the approval of a product (Vortioxetine hydrobromide) for registration by a regulatory authority in China. It is not a financial report, earnings release, or any form of regulatory filing related to financial performance or governance changes. The document is short (1629 characters) and serves to inform shareholders and investors about a business development update. It does not contain financial data, voting results, or management changes. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous filing that does not fit other specific categories, which corresponds to Regulatory Filings (RNS).
2023-12-27 English
CONTINUING CONNECTED TRANSACTIONS - (1) MASTER SALE AND PURCHASE AGREEMENT (2) MASTER PRODUCTS MANUFACTURING AND TRANSPORTATION SERVICES AGREEMENT (3) MASTER RESEARCH & DEVELOPMENT SERVICES AGREEM
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding continuing connected transactions involving master agreements for sale and purchase, manufacturing, transportation, and research & development services between the company and a connected party (Sichuan Kelun). It details the terms, pricing policies, annual caps, and actual transaction amounts. The document is lengthy (15,000 characters) and contains detailed contractual and transactional information rather than a simple notification or summary. It is not an annual report, earnings release, or management discussion. It is not a regulatory filing or report publication announcement because it contains substantive content about the agreements and transactions themselves. The document fits the category of Capital/Financing Update (CAP) as it relates to continuing connected transactions and contractual agreements affecting the company's business and financial dealings with a connected party, which is a form of capital or financing update under Hong Kong Listing Rules. Therefore, the appropriate classification is CAP with high confidence.
2023-12-13 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities for SSY Group Limited, including authorized and issued share capital, share options, repurchases, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and follows the format of a regulatory return under the Exchange Listing Rules. The content focuses on share capital changes, share repurchases, and confirmations by the company secretary, without any financial performance data, earnings, or management discussion. It is not an annual or interim report, earnings release, or investor presentation. The document is a regulatory filing reporting share capital movements and related confirmations, fitting the category of Regulatory Filings (RNS). The document length (9103 characters) and detailed tabular data confirm it is a substantive regulatory report rather than a brief announcement or certification only.
2023-12-01 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding an update on product development, specifically the approval for drug production and registration from a regulatory authority. It does not contain financial statements, detailed financial analysis, or regulatory certifications. The document is short (1991 characters) and serves to inform shareholders and investors about business progress rather than financial results or governance changes. It is not an annual report, interim report, earnings release, or any other detailed financial or governance filing. It is also not a report publication announcement since it does not mention any report being attached or published. The content fits best under a general regulatory announcement category that does not fit other specific categories, which is Regulatory Filings (RNS).
2023-12-01 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for SSY Group Limited. It references specific listing rules from the Stock Exchange of Hong Kong (Main Board Listing Rules and GEM Listing Rules) and details repurchase of shares and changes in issued shares. The content is regulatory in nature, confirming compliance with listing rules and legal requirements related to share capital changes. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is a formal disclosure of share capital changes, which fits the category of Share Issue/Capital Change announcements.
2023-11-28 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.